Our biomedical AI agents connect existing knowledge to identify drug-rescue opportunities for rare diseases.
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma

Atlas Discovery
Overview
AI-native pharma company
Company description As recorded 2026-11-08
Product & workflow
Source-reported As recorded 2026-10-28
Founders & team
Previously Rhizome Bio
Company history As recorded 2026-11-08
Shaamil Karim
Founder/CEOExcited about AI for predictive biology
Founder profile As recorded 2026-09-15
Sanjukta Bhattacharya
Founderexcited about making biology a tractable problem
Founder profile As recorded 2026-09-15
Christian Gensbigler
FounderPreviously MTS at Origin Bio (YC w26), theoretical biology at Johns Hopkins School of Medicine, math at Dartmouth
Founder profile As recorded 2026-09-15
3team members reported
Source-reported As recorded 2026-09-15
Founded 2026 · Source
News & product activity
Cohort membership
Summer 2026Summer 2026
Original evidence ↗Sources & observations
Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-11
- Product visualsNot documented
- Founders & originsTeam information
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2026 Q3 (quarter only)
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year





